Friday, February 5, 2010

Northeastern's Torchilin lands $1.4M NIH award

By Brendan Lynch

Video Gallery

MHT's Julie Donnelly: Pharmaceuticals find drug development partners in colleges

Funding drugs for rare diseases

MHT's Julie Donnelly: Life science startups finding investments

Related News

Volpa named to NuOrtho’s board [March 19, 2010]

Lifeline grows with broader patient monitoring [March 19, 2010]

FDA gives nod to Boston Scientific defibrillator [March 19, 2010]

UMassOnline brings Masson on as CTO [March 18, 2010]

Rhythmia Medical grabs $2.7M equity round [March 18, 2010]

A Northeastern University researcher has won a $1.4 million grant from the National Institutes of Health to develop nanocarrier drug delivery technology.

Vladimir Torchilin, a professor pharmaceutical sciences and the director of Northeastern’s Center for Pharmaceutical Biotechnology and Biomedicine, will use the funding to combine pharmaceutical nanotechnology with a new drug coating process. The combination of techniques is intended to carry insoluble drugs to their targets inside the body. The technique could make drugs passed over for their insolubility viable drug candidates again.

Torchilin will collaborate with researchers from Louisiana Tech University on the four-year grant.

In 2008, Torchilin won $1.5 million from the NIH for research on nanoscale pharmaceuticals.